Jazz Pharmaceuticals (NASDAQ:JAZZ) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-24. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Jazz Pharmaceuticals will report an earnings per share (EPS) of $6.16.

The announcement from Jazz Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Earnings History Snapshot

Last quarter the company beat EPS by $2.70, which was followed by a 2.31% drop in the share price the next day.

Here's a look at Jazz Pharmaceuticals's past performance and the resulting price change:

Performance of Jazz Pharmaceuticals Shares

Shares of Jazz Pharmaceuticals were trading at $172.19 as of February 20. Over the last 52-week period, shares are up 24.24%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Jazz Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.